NovaBay Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of NBY for the last quarter is 2.44 M USD, and it's 1.71% higher compared to the previous quarter. The net income of Q3 24 is -1.21 M USD.